๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma


Book ID
122719626
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
153 KB
Volume
10
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Phase II trial of 4โ€ฒ deoxydoxorubicin (D
โœ Christopher Rose; Thomas E. Lad; Lary J. Kilton; Joel Schor; Steven T. Rosen; Ar ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 162 KB

A phase II trial of 4' Deoxydoxorubicin (DXDX) was conducted in unresectable previously untreated non-small cell lung cancer patients. DXDX was administered every 3 weeks by short intravenous infusion at a starting dose of 30 mg/m2, with dose escalation to 40 mg/m2 toxicity permitting. Four response